Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 163, Issue 7, 2001, Pages 1683-1692

  Clancy, J P ^a   Bebok Z ^a   Ruiz, F ^a   King, C ^a   Jones, J ^a   Walker, L ^a   Greer, H ^a   Hong, J ^a   Wing, L ^a   Macaluso, M ^a   Lyrene, R ^a   Sorscher, E J ^a   Bedwell, D M ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 METHOXY N (3 SULFOPROPYL)QUINOLINIUM DERIVATIVE; CEFTAZIDIME; CHLORIDE ION; GENTAMICIN; QUINOLINE DERIVATIVE; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHLORIDE CONDUCTANCE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HYPERPOLARIZATION; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE MICROSCOPY; MALE; NOSE MUCOSA; POTENTIAL DIFFERENCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; STOP CODON; SWEAT TEST;

EID: 0034961464     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.163.7.2004001     Document Type: Article

References (37)

1. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA
2. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity
3. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR)
4. Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel
5. Role of CFTR in airway disease
6. Cystic fibrosis
7. CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP
8. CFTR as a cAMP-dependent regulator of sodium channels
9. Genotype-phenotype correlations in cystic fibrosis
10. Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis
11. CFTR nonsense mutations G542X and W1282X associated with severe reduction of CFTR mRNA in nasal epithelial cells
12. Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations
13. Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line
14. Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice
15. A pilot study of the effect of gentamicin on nasal potential difference measurements in cystic fibrosis patients carrying premature stop mutations
16. Growth and differentiation of human nasal epithelial cells in culture: Serum-free, hormone-supplemented medium and proteoglycan synthesis
17. Long-term culture of normal and cystic fibrosis epithelial cells grown under serum-free conditions
18. A method for the rapid detection of recombinant CFTR during gene therapy in cystic fibrosis
19. Cystic fibrosis transmembrane conductance regulator (CFTR) nucleotide-binding domain 1 (NBD-1) and CFTR truncated within NBD-1 target to the epithelial plasma membrane and increase anion permeability
20. In vivo nasal potential difference: Techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis
21. Relationship between airway ion transport and a mild pulmonary disease mutation in CFTR
22. A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: Partial restoration of nasal epithelial CFTR function
23. Correlation between genotype in patients with cystic fibroses
24. Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator mutations
25. A cystic fibrosis mutation associated with mild lung disease
26. DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis
27. The in vivo effects of milrinone on the airways of cystic fibrosis mice and human subjects
28. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis
29. Nasal application of the cationic lipsome DC-Chol:DOPE does not alter ion transport, lung fuction or bacterial growth
30. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis
31. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: A double-blind placebo-controlled trial
32. A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis
33. Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo
34. Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis
35. In vitro assessment of variables affecting the efficiency and efficacy of adenovirus-mediated gene transfer to cystic fibrosis airway epithelia